Individual results depend on baseline weight, dose tolerance, and adherence to the program
The medication demonstrated efficacy regardless of surgical procedure type
Still, its a good potential customer acquisition strategy for Novo Nordisk, Leventhal said, because its tapping into a retailer that has a very, very loyal and large customer base. Overall, GLP-1s are getting cheaper, he added, because companies like Novo Nordisk and Eli Lilly, which makes GLP-1s Zepbound and Mounjaro, want to compete with the compounding market
While results from weight loss medications wont happen overnight, when paired with a healthy diet and regular exercise, many people can see a total weight loss of 3% to 12% with some medications
The Weibull distribution model demonstrated that upper limits of 95% CIs of were all below 1 (Table S6), consistent with an early failure profile, indicating NAEs predominantly manifest during initial treatment phases